Cargando…
Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290961/ https://www.ncbi.nlm.nih.gov/pubmed/30564304 http://dx.doi.org/10.18632/oncotarget.26415 |
| _version_ | 1783380178814107648 |
|---|---|
| author | Hanson, Kimberley Robinson, Stephen D. Al-Yousuf, Karamallah Hendry, Adam E. Sexton, Darren W. Sherwood, Victoria Wheeler, Grant N. |
| author_facet | Hanson, Kimberley Robinson, Stephen D. Al-Yousuf, Karamallah Hendry, Adam E. Sexton, Darren W. Sherwood, Victoria Wheeler, Grant N. |
| author_sort | Hanson, Kimberley |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6290961 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62909612018-12-18 Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth Hanson, Kimberley Robinson, Stephen D. Al-Yousuf, Karamallah Hendry, Adam E. Sexton, Darren W. Sherwood, Victoria Wheeler, Grant N. Oncotarget Correction Impact Journals LLC 2018-11-27 /pmc/articles/PMC6290961/ /pubmed/30564304 http://dx.doi.org/10.18632/oncotarget.26415 Text en Copyright: © 2018 Hanson et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Hanson, Kimberley Robinson, Stephen D. Al-Yousuf, Karamallah Hendry, Adam E. Sexton, Darren W. Sherwood, Victoria Wheeler, Grant N. Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth |
| title | Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth |
| title_full | Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth |
| title_fullStr | Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth |
| title_full_unstemmed | Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth |
| title_short | Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth |
| title_sort | correction: the anti-rheumatic drug, leflunomide, synergizes with mek inhibition to suppress melanoma growth |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290961/ https://www.ncbi.nlm.nih.gov/pubmed/30564304 http://dx.doi.org/10.18632/oncotarget.26415 |
| work_keys_str_mv | AT hansonkimberley correctiontheantirheumaticdrugleflunomidesynergizeswithmekinhibitiontosuppressmelanomagrowth AT robinsonstephend correctiontheantirheumaticdrugleflunomidesynergizeswithmekinhibitiontosuppressmelanomagrowth AT alyousufkaramallah correctiontheantirheumaticdrugleflunomidesynergizeswithmekinhibitiontosuppressmelanomagrowth AT hendryadame correctiontheantirheumaticdrugleflunomidesynergizeswithmekinhibitiontosuppressmelanomagrowth AT sextondarrenw correctiontheantirheumaticdrugleflunomidesynergizeswithmekinhibitiontosuppressmelanomagrowth AT sherwoodvictoria correctiontheantirheumaticdrugleflunomidesynergizeswithmekinhibitiontosuppressmelanomagrowth AT wheelergrantn correctiontheantirheumaticdrugleflunomidesynergizeswithmekinhibitiontosuppressmelanomagrowth |